# Ernexa Therapeutics Inc.: Form 8-K/A, filed Oct 1, 2021

- Company: [Ernexa Therapeutics Inc.](/companies/erna.md) (CIK 748592)
- Form: 8-K/A
- Filed: 2021-10-01
- Accepted by EDGAR: Oct 1, 2021, 16:31 ET
- Period: 2021-07-16
- Accession: 0001140361-21-033284
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/748592/000114036121033284/brhc10029466_8ka.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/748592/000114036121033284/

## Items reported

- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/748592/000114036121033284/brhc10029466_8ka.htm

Filed Oct 1, 2021.
Source: SEC EDGAR, the filing index for accession 0001140361-21-033284. Last ingested by Listed: Nov 6, 2026, 17:52 ET. No prices; not investment advice.